Megan J Dailey

Summary

Affiliation: The Johns Hopkins Hospital
Country: USA

Publications

  1. pmc Glucagon-like peptide 1 and appetite
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Trends Endocrinol Metab 24:85-91. 2013
  2. pmc Disassociation between preprandial gut peptide release and food-anticipatory activity
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205, USA
    Endocrinology 153:132-42. 2012
  3. pmc Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Am J Physiol Endocrinol Metab 301:E1184-90. 2011
  4. pmc Inositol polyphosphate multikinase: an emerging player for the central action of AMP-activated protein kinase
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Biochem Biophys Res Commun 421:1-3. 2012
  5. doi Nutrient specific feeding and endocrine effects of jejunal infusions
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Obesity (Silver Spring) 18:904-10. 2010
  6. pmc Intestinal feedback signaling and satiety
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Ave, Baltimore, MD 21205, United States
    Physiol Behav 105:77-81. 2011
  7. pmc Minireview: Gut peptides: targets for antiobesity drug development?
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Endocrinology 150:2526-30. 2009
  8. pmc Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain
    Anutosh Chakraborty
    The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cell 143:897-910. 2010

Collaborators

  • Solomon H Snyder
  • Nicholas T Bello
  • Timothy H Moran
  • Anutosh Chakraborty
  • Esteban Mezey
  • James J Potter
  • Michael A Koldobskiy
  • Adele M Snowman
  • David Maag
  • Alex S Huang
  • Seyun Kim
  • Masoumeh Saleh
  • Micah Maxwell
  • Krishna R Juluri

Detail Information

Publications8

  1. pmc Glucagon-like peptide 1 and appetite
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Trends Endocrinol Metab 24:85-91. 2013
    ..Understanding the mechanisms underlying the appetite-suppressive effects of GLP-1 may help in developing targeted treatments for obesity...
  2. pmc Disassociation between preprandial gut peptide release and food-anticipatory activity
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205, USA
    Endocrinology 153:132-42. 2012
    ..These data suggest that separate mechanisms may underlie the preprandial increases in ghrelin and GLP-1 and changes in FAA, insulin, and glucose...
  3. pmc Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Am J Physiol Endocrinol Metab 301:E1184-90. 2011
    ..Whether increased secretion of additional gut peptides is also necessary for such suppressions remains to be determined...
  4. pmc Inositol polyphosphate multikinase: an emerging player for the central action of AMP-activated protein kinase
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Biochem Biophys Res Commun 421:1-3. 2012
    ..Here we review and discuss a novel role for the hypothalamic IPMK signaling in the control of AMPK and central energy homeostasis...
  5. doi Nutrient specific feeding and endocrine effects of jejunal infusions
    Megan J Dailey
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Obesity (Silver Spring) 18:904-10. 2010
    ..Thus, particular nutrients are more effective at producing decreases in food intake, body weight, and inducing changes in peptide levels and could lead to a novel therapy for obesity...
  6. pmc Intestinal feedback signaling and satiety
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Ross 618, 720 Rutland Ave, Baltimore, MD 21205, United States
    Physiol Behav 105:77-81. 2011
    ..Thus, gut peptides are clear targets for future obesity therapeutic developments...
  7. pmc Minireview: Gut peptides: targets for antiobesity drug development?
    Timothy H Moran
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Endocrinology 150:2526-30. 2009
    ..Whether any individual approach will have significant long-term efficacy remains to be demonstrated. Approaches that target multiple systems may hold the most promise...
  8. pmc Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain
    Anutosh Chakraborty
    The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Cell 143:897-910. 2010
    ..IP6K1 knockout mice manifest insulin sensitivity and are resistant to obesity elicited by high-fat diet or aging. Inhibition of IP6K1 may afford a therapeutic approach to obesity and diabetes...